Behavioural Addiction and Genetics in Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

March 31, 2016

Conditions
Parkinson DiseaseImpulse Control Disorders
Interventions
GENETIC

Blood Sampling and DNA collection

"One blood sampling during the study. A small number (1 to 5) of markers type tag SNPs or coding SNP (single nucleotide polymorphism, SNP) will be selected for each of the selected genes, for a total of 50 markers (representing 20 to 25 genes). Non-silent coding SNP, that may have a functional effect, will be included as a priority. Genotyping is carried out by the method of genotyping VeraCode Goldengate."

Trial Locations (1)

75013

Groupe Hospitalier La Pitié Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02319395 - Behavioural Addiction and Genetics in Parkinson's Disease | Biotech Hunter | Biotech Hunter